Scientists at the Scripps Research Institute have developed the T7-ORACLE platform, accelerating synthetic protein evolution 100,000 times faster than natural processes. This system, presented in “Science”, enables the creation of proteins with novel functions for treating cancer, neurodegenerative diseases, and other conditions, bypassing lengthy traditional methods. According to Pete Schultz, the institute’s president, it’s a “fast-forward button” for evolution without harming the cellular genome.
T7-ORACLE uses “E. coli” bacteria with an artificial DNA replication system from the T7 bacteriophage, enabling hypermutation and continuous evolution of biomacromolecules. Unlike labor-intensive directed evolution, where mutations and selection take weeks, this orthogonal system operates independently of the cell’s machinery, targeting only plasmid DNA and speeding up the process without manual intervention.
The system incorporates a modified T7 DNA polymerase with a high error rate, allowing mutations to be introduced at an exceptional speed. As Christian Dircks noted, the results align with clinical data on resistance and sometimes reveal new combinations with improved properties. Additionally, as of August 12, 2025, the technology can integrate with AI to predict mutations, amplifying its potential.
This breakthrough simplifies the development of therapeutic proteins while preserving the integrity of host cells. Future research may expand T7-ORACLE’s application to more complex organisms, promising a revolution in biotechnology and personalized medicine.
#space #science #educational #technology
